Cardiovascular Safety of Tocilizumab Versus Tumor Necrosis Factor Inhibitors in Patients With Rheumatoid Arthritis: A Multi-Database Cohort Study
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cardiovascular Safety of Tocilizumab Versus Tumor Necrosis Factor Inhibitors in Patients With Rheumatoid Arthritis: A Multi-Database Cohort Study
Authors
Keywords
-
Journal
Arthritis & Rheumatology
Volume 69, Issue 6, Pages 1154-1164
Publisher
Wiley
Online
2017-03-01
DOI
10.1002/art.40084
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A US Claims-Based Analysis of Real-World Lipid-Lowering Treatment Patterns in Patients With High Cardiovascular Disease Risk or a Previous Coronary Event
- (2016) Ruben G.W. Quek et al. AMERICAN JOURNAL OF CARDIOLOGY
- Comparative effects of biologics on cardiovascular risk among older patients with rheumatoid arthritis
- (2016) Jie Zhang et al. ANNALS OF THE RHEUMATIC DISEASES
- Association of hyperlipidaemia, inflammation and serological status and coronary heart disease among patients with rheumatoid arthritis: data from the National Veterans Health Administration
- (2015) Iris Navarro-Millán et al. ANNALS OF THE RHEUMATIC DISEASES
- Comparison of lipid and lipid-associated cardiovascular risk marker changes after treatment with tocilizumab or adalimumab in patients with rheumatoid arthritis
- (2015) Cem Gabay et al. ANNALS OF THE RHEUMATIC DISEASES
- The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis
- (2015) Camille Roubille et al. ANNALS OF THE RHEUMATIC DISEASES
- Active-comparator design and new-user design in observational studies
- (2015) Kazuki Yoshida et al. Nature Reviews Rheumatology
- Association Between Lipid Levels and Major Adverse Cardiovascular Events in Rheumatoid Arthritis Compared to Non-Rheumatoid Arthritis Patients
- (2015) Katherine P. Liao et al. Arthritis & Rheumatology
- An Evaluation of Risk Factors for Major Adverse Cardiovascular Events During Tocilizumab Therapy
- (2015) Vijay U. Rao et al. Arthritis & Rheumatology
- 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis
- (2015) Jasvinder A. Singh et al. Arthritis & Rheumatology
- Validity of Claims-Based Stroke Algorithms in Contemporary Medicare Data: Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study Linked With Medicare Claims
- (2014) H. Kumamaru et al.
- Tumor Necrosis Factor- Inhibitor Treatment and the Risk of Incident Cardiovascular Events in Patients with Early Rheumatoid Arthritis: A Nested Case-control Study
- (2014) R. J. Desai et al. JOURNAL OF RHEUMATOLOGY
- Cardiovascular Risk in Rheumatoid Arthritis: Comparing TNF-α Blockade with Nonbiologic DMARDs
- (2013) Daniel H. Solomon et al. AMERICAN JOURNAL OF MEDICINE
- Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial
- (2013) Cem Gabay et al. LANCET
- Changes in lipid levels with inflammation and therapy in RA: a maturing paradigm
- (2013) Jamie Robertson et al. Nature Reviews Rheumatology
- Metrics for covariate balance in cohort studies of causal effects
- (2013) Jessica M. Franklin et al. STATISTICS IN MEDICINE
- Supplementing claims data with outpatient laboratory test results to improve confounding adjustment in effectiveness studies of lipid-lowering treatments
- (2012) Sebastian Schneeweiss et al. BMC Medical Research Methodology
- One-to-many propensity score matching in cohort studies
- (2012) Jeremy A. Rassen et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- A systematic review of validated methods for identifying cerebrovascular accident or transient ischemic attack using administrative data
- (2012) Susan E. Andrade et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease
- (2011) E. Myasoedova et al. ANNALS OF THE RHEUMATIC DISEASES
- A combined comorbidity score predicted mortality in elderly patients better than existing scores
- (2011) Joshua J. Gagne et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Validation of rheumatoid arthritis diagnoses in health care utilization data
- (2011) Seo Young Kim et al. ARTHRITIS RESEARCH & THERAPY
- Tumour necrosis factor antagonist use and associated risk reduction of cardiovascular events among patients with rheumatoid arthritis
- (2010) J. D. Greenberg et al. ANNALS OF THE RHEUMATIC DISEASES
- Explaining the cardiovascular risk associated with rheumatoid arthritis: traditional risk factors versus markers of rheumatoid arthritis severity
- (2010) D. H. Solomon et al. ANNALS OF THE RHEUMATIC DISEASES
- Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies
- (2010) Peter C. Austin PHARMACEUTICAL STATISTICS
- Systematic review and meta-analysis: Anti-tumor necrosis factor α therapy and cardiovascular events in rheumatoid arthritis
- (2010) Cheryl Barnabe et al. ARTHRITIS CARE & RESEARCH
- Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION study
- (2009) G. Jones et al. ANNALS OF THE RHEUMATIC DISEASES
- Risk of cardiovascular mortality in patients with rheumatoid arthritis: A meta-analysis of observational studies
- (2008) J. Antonio Aviña-Zubieta et al. ARTHRITIS AND RHEUMATISM
- Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial
- (2008) Josef S Smolen et al. LANCET
- Development of a health care utilisation data-based index for rheumatoid arthritis severity: a preliminary study
- (2008) Gladys Ting et al. ARTHRITIS RESEARCH & THERAPY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now